Ignite Creation Date:
2025-12-25 @ 3:20 AM
Ignite Modification Date:
2025-12-31 @ 5:59 PM
Study NCT ID:
NCT00454805
Status:
COMPLETED
Last Update Posted:
2016-08-03
First Post:
2007-03-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer.
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-03
Start Date Type:
None
Primary Completion Date:
2008-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04
Completion Date Type:
ACTUAL
First Submit Date:
2007-03-29
First Submit QC Date:
None
Study First Post Date:
2007-04-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-04-25
Results First Submit QC Date:
None
Results First Post Date:
2012-11-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-04-12
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-07-06
Last Update Post Date:
2016-08-03
Last Update Post Date Type:
ESTIMATED